An observational study in Brain Tumor, Recurrent, Vestibular Schwannoma and Brainstem Neoplasm, sponsored by University Hospital Tuebingen. Completed at 1 site in Germany. Per ClinicalTrials.gov, last updated 2022-11-04.
Sponsored by University Hospital Tuebingen · Observational
Intraoperative Monitoring of Heart rate variability, Blood pressure variability, Baroreceptorsensivity etc.
1,960 studies on the registry are indexed under Brain Neoplasms; 516 are open to participants now.
This study's enrollment of 103 is close to the median of 100 across 380 observational studies indexed under Brain Neoplasms.
Browse Brain Neoplasms studies →University Hospital Tuebingen is the lead sponsor of 476 studies on the registry; 104 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Brain tumor patients
Exclusion Criteria:
Brain stem associated tumors
Procedure: Intraoperative Monitoring during resection of brain tumor
Tumors without brain stem assocation
Procedure: Intraoperative Monitoring during resection of brain tumor
Intraoperative Monitoring during resection of brain tumor
Heart rate variability (HRV)
Comparison of HRV in the 2 groups (brain stem-associated vs. non associated surgery)
Time frame: intraoperatively
Rate of cardiovascular complications
Comparison of no. of cardiovascular complications (cardiac arrest, sudden tachy/bradyarryhthmia, hyper/hypotension, trigeminocardiac reflex) in the 2 groups
Time frame: intraoperatively
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital Tuebingen